Regeneron Pharmaceuticals, Inc. insider trading
In the last twelve months insiders at Regeneron Pharmaceuticals, Inc. filed 84 open-market sales worth $12.9 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Mccourt Marion, EVP Commercial, sold 1,131 shares at $857.39 on 3 September 2026, filed 3 September 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 3 September 2026 | Mccourt Marion | EVP Commercial | Sale | 1,131 | $857.39 | $969,708 | Form 4 |
| 2 September 2026 | Mccourt Marion | EVP Commercial | Sale | 1,215 | $850.00 | $1.0 million | Form 4 |
| 2 September 2026 | Guarini Kathryn | Director | Sale | 400 | $850.00 | $340,000 | Form 4 |
| 10 August 2026 | Guarini Kathryn | Director | Sale | 400 | $800.00 | $320,000 | Form 4 |
| 10 August 2026 | Zoghbi Huda Y | Director | Sale | 800 | $800.00 | $640,000 | Form 4 |
| 2 July 2026 | Ryan Arthur F | Director | Sale | 200 | $650.15 | $130,030 | Form 4 |
| 1 May 2026 | Ryan Arthur F | Director | Sale | 5 | $701.76 | $3,509 | Form 4 |
| 1 May 2026 | Ryan Arthur F | Director | Sale | 15 | $702.46 | $10,537 | Form 4 |
| 1 May 2026 | Ryan Arthur F | Director | Sale | 24 | $703.46 | $16,883 | Form 4 |
| 1 May 2026 | Ryan Arthur F | Director | Sale | 15 | $704.28 | $10,564 | Form 4 |
| 1 May 2026 | Ryan Arthur F | Director | Sale | 14 | $705.56 | $9,878 | Form 4 |
| 1 May 2026 | Ryan Arthur F | Director | Sale | 7 | $706.74 | $4,947 | Form 4 |
| 1 May 2026 | Ryan Arthur F | Director | Sale | 4 | $707.40 | $2,830 | Form 4 |
| 1 May 2026 | Ryan Arthur F | Director | Sale | 6 | $709.45 | $4,257 | Form 4 |
| 1 May 2026 | Ryan Arthur F | Director | Sale | 2 | $710.87 | $1,422 | Form 4 |
| 1 May 2026 | Ryan Arthur F | Director | Sale | 5 | $711.49 | $3,557 | Form 4 |
| 1 May 2026 | Ryan Arthur F | Director | Sale | 1 | $712.09 | $712 | Form 4 |
| 1 May 2026 | Ryan Arthur F | Director | Sale | 2 | $714.13 | $1,428 | Form 4 |
| 1 April 2026 | Ryan Arthur F | Director | Sale | 1 | $771.32 | $771 | Form 4 |
| 1 April 2026 | Ryan Arthur F | Director | Sale | 3 | $772.76 | $2,318 | Form 4 |
| 1 April 2026 | Ryan Arthur F | Director | Sale | 8 | $773.59 | $6,189 | Form 4 |
| 1 April 2026 | Ryan Arthur F | Director | Sale | 8 | $774.58 | $6,197 | Form 4 |
| 1 April 2026 | Ryan Arthur F | Director | Sale | 14 | $775.58 | $10,858 | Form 4 |
| 1 April 2026 | Ryan Arthur F | Director | Sale | 13 | $776.62 | $10,096 | Form 4 |
| 1 April 2026 | Ryan Arthur F | Director | Sale | 9 | $777.42 | $6,997 | Form 4 |
| 1 April 2026 | Ryan Arthur F | Director | Sale | 4 | $778.24 | $3,113 | Form 4 |
| 1 April 2026 | Ryan Arthur F | Director | Sale | 40 | $779.71 | $31,188 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 7 | $777.46 | $5,442 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 2 | $778.30 | $1,557 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 5 | $779.69 | $3,898 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 3 | $780.69 | $2,342 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 2 | $781.21 | $1,562 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 2 | $782.62 | $1,565 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 10 | $783.62 | $7,836 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 9 | $784.48 | $7,060 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 11 | $785.48 | $8,640 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 7 | $786.61 | $5,506 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 2 | $787.34 | $1,575 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 20 | $788.96 | $15,779 | Form 4 |
| 2 March 2026 | Ryan Arthur F | Director | Sale | 20 | $789.28 | $15,786 | Form 4 |
| 19 February 2026 | Zoghbi Huda Y | Director | Sale | 49 | $774.68 | $37,959 | Form 4 |
| 19 February 2026 | Zoghbi Huda Y | Director | Sale | 50 | $775.50 | $38,775 | Form 4 |
| 19 February 2026 | Zoghbi Huda Y | Director | Sale | 53 | $778.47 | $41,259 | Form 4 |
| 19 February 2026 | Zoghbi Huda Y | Director | Sale | 208 | $779.55 | $162,146 | Form 4 |
| 19 February 2026 | Zoghbi Huda Y | Director | Sale | 331 | $780.45 | $258,329 | Form 4 |
| 19 February 2026 | Zoghbi Huda Y | Director | Sale | 209 | $781.28 | $163,288 | Form 4 |
| 19 February 2026 | Zoghbi Huda Y | Director | Sale | 298 | $782.10 | $233,066 | Form 4 |
| 19 February 2026 | Zoghbi Huda Y | Director | Sale | 220 | $783.29 | $172,324 | Form 4 |
| 19 February 2026 | Zoghbi Huda Y | Director | Sale | 160 | $784.45 | $125,512 | Form 4 |
| 19 February 2026 | Zoghbi Huda Y | Director | Sale | 56 | $785.61 | $43,994 | Form 4 |
| 19 February 2026 | Zoghbi Huda Y | Director | Sale | 4 | $790.00 | $3,160 | Form 4 |
| 9 February 2026 | Pitofsky Jason | SVP Controller | Sale | 20 | $775.95 | $15,519 | Form 4 |
| 9 February 2026 | Pitofsky Jason | SVP Controller | Sale | 521 | $776.43 | $404,520 | Form 4 |
| 9 February 2026 | Pitofsky Jason | SVP Controller | Sale | 391 | $777.51 | $304,006 | Form 4 |
| 9 February 2026 | Pitofsky Jason | SVP Controller | Sale | 563 | $778.35 | $438,211 | Form 4 |
| 9 February 2026 | Pitofsky Jason | SVP Controller | Sale | 205 | $779.56 | $159,810 | Form 4 |
| 9 February 2026 | Pitofsky Jason | SVP Controller | Sale | 75 | $780.06 | $58,504 | Form 4 |
| 9 February 2026 | Pitofsky Jason | SVP Controller | Sale | 26 | $781.37 | $20,316 | Form 4 |
| 9 February 2026 | Pitofsky Jason | SVP Controller | Sale | 37 | $782.67 | $28,959 | Form 4 |
| 9 February 2026 | Pitofsky Jason | SVP Controller | Sale | 144 | $783.23 | $112,785 | Form 4 |
| 9 February 2026 | Pitofsky Jason | SVP Controller | Sale | 1 | $784.66 | $785 | Form 4 |
| 9 February 2026 | Pitofsky Jason | SVP Controller | Sale | 53 | $785.72 | $41,643 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 1 | $775.63 | $776 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 10 | $776.59 | $7,766 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 57 | $777.56 | $44,321 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 12 | $778.53 | $9,342 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 5 | $779.41 | $3,897 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 1 | $780.09 | $780 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 5 | $781.48 | $3,907 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 1 | $782.53 | $783 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 3 | $783.34 | $2,350 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 1 | $784.59 | $785 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 1 | $785.71 | $786 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 2 | $786.29 | $1,573 | Form 4 |
| 9 February 2026 | Ryan Arthur F | Director | Sale | 1 | $787.82 | $788 | Form 4 |
| 7 January 2026 | Bassler Bonnie L | Director | Sale | 1,500 | $800.00 | $1.2 million | Form 4 |
| 20 November 2025 | Bassler Bonnie L | Director | Sale | 760 | $750.00 | $570,000 | Form 4 |
| 7 November 2025 | Pitofsky Jason | VP Controller | Sale | 431 | $651.43 | $280,766 | Form 4 |
| 29 October 2025 | Poon Christine A | Director | Sale | 650 | $652.68 | $424,242 | Form 4 |
| 29 October 2025 | Poon Christine A | Director | Sale | 2,735 | $653.50 | $1.8 million | Form 4 |
Open-market purchases (code P) and sales (code S) only. Option exercises, grants, tax withholding and gifts are not shown. A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Regeneron Pharmaceuticals, Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.